118 related articles for article (PubMed ID: 30068243)
1. Somatic mutations of cell-free circulating DNA detected by targeted next-generation sequencing and digital droplet PCR in classical Hodgkin lymphoma.
Bessi L; Viailly PJ; Bohers E; Ruminy P; Maingonnat C; Bertrand P; Vasseur N; Beaussire L; Cornic M; Etancelin P; Camus V; Picquenot JM; Tilly H; Stamatoullas A; Jardin F
Leuk Lymphoma; 2019 Feb; 60(2):498-502. PubMed ID: 30068243
[No Abstract] [Full Text] [Related]
2. Detection and prognostic value of recurrent exportin 1 mutations in tumor and cell-free circulating DNA of patients with classical Hodgkin lymphoma.
Camus V; Stamatoullas A; Mareschal S; Viailly PJ; Sarafan-Vasseur N; Bohers E; Dubois S; Picquenot JM; Ruminy P; Maingonnat C; Bertrand P; Cornic M; Tallon-Simon V; Becker S; Veresezan L; Frebourg T; Vera P; Bastard C; Tilly H; Jardin F
Haematologica; 2016 Sep; 101(9):1094-101. PubMed ID: 27479820
[TBL] [Abstract][Full Text] [Related]
3. Droplet-based digital PCR and next generation sequencing for monitoring circulating tumor DNA: a cancer diagnostic perspective.
Postel M; Roosen A; Laurent-Puig P; Taly V; Wang-Renault SF
Expert Rev Mol Diagn; 2018 Jan; 18(1):7-17. PubMed ID: 29115895
[TBL] [Abstract][Full Text] [Related]
4. Monitoring Melanoma Using Circulating Free DNA.
Diefenbach RJ; Lee JH; Rizos H
Am J Clin Dermatol; 2019 Feb; 20(1):1-12. PubMed ID: 30374893
[TBL] [Abstract][Full Text] [Related]
5. Precision Monitoring by Next-Generation Sequencing in Lymphoma: Circulating Tumor DNA as a New Biomarker.
Gordon LI
Oncology (Williston Park); 2016 Aug; 30(8):745-6. PubMed ID: 27539625
[No Abstract] [Full Text] [Related]
6. Monitoring of somatic mutations in circulating cell-free DNA by digital PCR and next-generation sequencing during afatinib treatment in patients with lung adenocarcinoma positive for EGFR activating mutations.
Iwama E; Sakai K; Azuma K; Harada T; Harada D; Nosaki K; Hotta K; Ohyanagi F; Kurata T; Fukuhara T; Akamatsu H; Goto K; Shimose T; Kishimoto J; Nakanishi Y; Nishio K; Okamoto I
Ann Oncol; 2017 Jan; 28(1):136-141. PubMed ID: 28177428
[TBL] [Abstract][Full Text] [Related]
7. Quantification of mutant alleles in circulating tumor DNA can predict survival in lung cancer.
Yang X; Zhuo M; Ye X; Bai H; Wang Z; Sun Y; Zhao J; An T; Duan J; Wu M; Wang J
Oncotarget; 2016 Apr; 7(15):20810-24. PubMed ID: 26989078
[TBL] [Abstract][Full Text] [Related]
8. Digital PCR for quantification of recurrent and potentially actionable somatic mutations in circulating free DNA from patients with diffuse large B-cell lymphoma.
Camus V; Sarafan-Vasseur N; Bohers E; Dubois S; Mareschal S; Bertrand P; Viailly PJ; Ruminy P; Maingonnat C; Lemasle E; Stamatoullas A; Picquenot JM; Cornic M; Beaussire L; Bastard C; Frebourg T; Tilly H; Jardin F
Leuk Lymphoma; 2016 Sep; 57(9):2171-9. PubMed ID: 26883583
[TBL] [Abstract][Full Text] [Related]
9. Detection of classical Hodgkin lymphoma specific sequence in peripheral blood using a next-generation sequencing approach.
Oki Y; Neelapu SS; Fanale M; Kwak LW; Fayad L; Rodriguez MA; Wallace M; Klinger M; Carlton V; Kong K; Faham M; Younes A
Br J Haematol; 2015 Jun; 169(5):689-93. PubMed ID: 25818067
[TBL] [Abstract][Full Text] [Related]
10. Whole exome sequencing in families at high risk for Hodgkin lymphoma: identification of a predisposing mutation in the KDR gene.
Rotunno M; McMaster ML; Boland J; Bass S; Zhang X; Burdett L; Hicks B; Ravichandran S; Luke BT; Yeager M; Fontaine L; Hyland PL; Goldstein AM; ; ; Chanock SJ; Caporaso NE; Tucker MA; Goldin LR
Haematologica; 2016 Jul; 101(7):853-60. PubMed ID: 27365461
[TBL] [Abstract][Full Text] [Related]
11. Detection fidelity of AR mutations in plasma derived cell-free DNA.
Goldstein A; Toro PV; Lee J; Silberstein JL; Nakazawa M; Waters I; Cravero K; Chu D; Cochran RL; Kim M; Shinn D; Torquato S; Hughes RM; Pallavajjala A; Carducci MA; Paller CJ; Denmeade SR; Kressel B; Trock BJ; Eisenberger MA; Antonarakis ES; Park BH; Hurley PJ
Oncotarget; 2017 Feb; 8(9):15651-15662. PubMed ID: 28152506
[TBL] [Abstract][Full Text] [Related]
12. Methods for Measuring ctDNA in Lymphomas.
Rossi D; Condoluci A; Spina V; Gaidano G
Methods Mol Biol; 2019; 1881():253-265. PubMed ID: 30350211
[TBL] [Abstract][Full Text] [Related]
13. Whole genome amplification of cell-free DNA enables detection of circulating tumor DNA mutations from fingerstick capillary blood.
Gyanchandani R; Kvam E; Heller R; Finehout E; Smith N; Kota K; Nelson JR; Griffin W; Puhalla S; Brufsky AM; Davidson NE; Lee AV
Sci Rep; 2018 Nov; 8(1):17313. PubMed ID: 30470782
[TBL] [Abstract][Full Text] [Related]
14. Droplet digital PCR for detection and quantification of circulating tumor DNA in plasma of head and neck cancer patients.
van Ginkel JH; Huibers MMH; van Es RJJ; de Bree R; Willems SM
BMC Cancer; 2017 Jun; 17(1):428. PubMed ID: 28629339
[TBL] [Abstract][Full Text] [Related]
15. Circulating Cell-Free Tumor DNA Analysis of 50 Genes by Next-Generation Sequencing in the Prospective MOSCATO Trial.
Jovelet C; Ileana E; Le Deley MC; Motté N; Rosellini S; Romero A; Lefebvre C; Pedrero M; Pata-Merci N; Droin N; Deloger M; Massard C; Hollebecque A; Ferté C; Boichard A; Postel-Vinay S; Ngo-Camus M; De Baere T; Vielh P; Scoazec JY; Vassal G; Eggermont A; André F; Soria JC; Lacroix L
Clin Cancer Res; 2016 Jun; 22(12):2960-8. PubMed ID: 26758560
[TBL] [Abstract][Full Text] [Related]
16. Highly sensitive
Drandi D; Genuardi E; Dogliotti I; Ferrante M; Jiménez C; Guerrini F; Schirico ML; Mantoan B; Muccio V; Lia G; Zaccaria GM; Omedè P; Passera R; Orsucci L; Benevolo G; Cavallo F; Galimberti S; Sanz RG; Boccadoro M; Ladetto M; Ferrero S
Haematologica; 2018 Jun; 103(6):1029-1037. PubMed ID: 29567768
[TBL] [Abstract][Full Text] [Related]
17. Comprehensive Genomic Profiling of Hodgkin Lymphoma Reveals Recurrently Mutated Genes and Increased Mutation Burden.
Liang WS; Vergilio JA; Salhia B; Huang HJ; Oki Y; Garrido-Laguna I; Park H; Westin JR; Meric-Bernstam F; Fabrizio D; Miller VA; Stephens PJ; Fanale MA; Ross JS; Janku F
Oncologist; 2019 Feb; 24(2):219-228. PubMed ID: 30108156
[TBL] [Abstract][Full Text] [Related]
18. Next-generation sequencing discoveries in lymphoma.
Slack GW; Gascoyne RD
Adv Anat Pathol; 2013 Mar; 20(2):110-6. PubMed ID: 23399796
[TBL] [Abstract][Full Text] [Related]
19. Analysis of Circulating Tumor DNA.
Mithraprabhu S; Spencer A
Methods Mol Biol; 2018; 1792():129-145. PubMed ID: 29797256
[TBL] [Abstract][Full Text] [Related]
20. Bringing circulating tumor DNA to the clinic in Hodgkin lymphoma.
Kurtz DM
Haematologica; 2021 Jan; 106(1):5-6. PubMed ID: 33386712
[No Abstract] [Full Text] [Related]
[Next] [New Search]
